Advertisement
Canada markets closed
  • S&P/TSX

    22,320.87
    +120.08 (+0.54%)
     
  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     
  • DOW

    39,069.59
    +4.33 (+0.01%)
     
  • CAD/USD

    0.7319
    +0.0035 (+0.48%)
     
  • CRUDE OIL

    77.80
    +0.93 (+1.21%)
     
  • Bitcoin CAD

    94,312.27
    +225.50 (+0.24%)
     
  • CMC Crypto 200

    1,446.00
    -22.10 (-1.51%)
     
  • GOLD FUTURES

    2,335.20
    -2.00 (-0.09%)
     
  • RUSSELL 2000

    2,069.67
    +21.26 (+1.04%)
     
  • 10-Yr Bond

    4.4670
    -0.0080 (-0.18%)
     
  • NASDAQ

    16,920.79
    +184.76 (+1.10%)
     
  • VOLATILITY

    11.93
    -0.84 (-6.58%)
     
  • FTSE

    8,317.59
    -21.64 (-0.26%)
     
  • NIKKEI 225

    38,646.11
    -457.11 (-1.17%)
     
  • CAD/EUR

    0.6744
    +0.0011 (+0.16%)
     

Philips clarifies respiratory device replacement numbers after new FDA rebuke

AMSTERDAM, April 14 (Reuters) - Philips clarified on Friday that 2.2 million devices it has repaired or replaced in a major recall of respiratory devices are actually in the hands of patients in the United States.

The Dutch healthcare equipment maker issued a statement clarifying progress of the recall program underway since 2021 after the FDA issued a statement on April 13 saying that the number of devices the company had replaced was "considerably less" than the 2.46 million indicated on the company's website.

Philips shares were down 2.7% at 16.32 euros at 0842 GMT in Amsterdam. (Reporting by Toby Sterling; Editing by Toby Chopra)